[{"address1": "7800 Susquehanna St.", "address2": "Suite 505", "city": "Pittsburgh", "state": "PA", "zip": "15208", "country": "United States", "phone": "412-901-0315", "website": "https://www.lipella.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jonathan  Kaufman M.B.A., Ph.D.", "age": 58, "title": "Co-Founder, Chairman, CEO, President, Secretary & Treasurer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 204133, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael B. Chancellor M.D.", "age": 66, "title": "Co-Founder, Chief Medical Officer & Director", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 195833, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas  Johnston CPA", "age": 39, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 185000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michele  Gruber", "title": "Director of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Katie  Johnston", "title": "Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.28, "open": 2.17, "dayLow": 2.16, "dayHigh": 2.32, "regularMarketPreviousClose": 2.28, "regularMarketOpen": 2.17, "regularMarketDayLow": 2.16, "regularMarketDayHigh": 2.32, "payoutRatio": 0.0, "beta": 0.146, "forwardPE": -0.71871877, "volume": 18214, "regularMarketVolume": 18214, "averageVolume": 2339034, "averageVolume10days": 57440, "averageDailyVolume10Day": 57440, "bid": 1.64, "ask": 2.88, "bidSize": 2, "askSize": 2, "marketCap": 2780395, "fiftyTwoWeekLow": 2.02, "fiftyTwoWeekHigh": 12.0, "priceToSalesTrailing12Months": 5.750166, "fiftyDayAverage": 2.96082, "twoHundredDayAverage": 3.47179, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1437163, "profitMargins": 0.0, "floatShares": 853799, "sharesOutstanding": 1208920, "sharesShort": 58196, "sharesShortPriorMonth": 30821, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0481, "heldPercentInsiders": 0.24348, "heldPercentInstitutions": 0.06102, "shortRatio": 0.01, "shortPercentOfFloat": 0.059, "impliedSharesOutstanding": 1208920, "bookValue": 1.337, "priceToBook": 1.7201945, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -4263476, "trailingEps": -4.29, "forwardEps": -3.2, "lastSplitFactor": "1:8", "lastSplitDate": 1731024000, "enterpriseToRevenue": 2.972, "enterpriseToEbitda": -0.33, "52WeekChange": -0.6484375, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 2.2999, "targetHighPrice": 10.0, "targetLowPrice": 10.0, "targetMeanPrice": 10.0, "targetMedianPrice": 10.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 1353734, "totalCashPerShare": 1.12, "ebitda": -4355956, "totalDebt": 70830, "quickRatio": 1.975, "currentRatio": 2.966, "totalRevenue": 483533, "debtToEquity": 4.855, "revenuePerShare": 0.505, "returnOnAssets": -1.0894799, "returnOnEquity": -2.3167, "grossProfits": -2521518, "freeCashflow": -2148772, "operatingCashflow": -3688044, "revenueGrowth": -0.228, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -18.15644, "financialCurrency": "USD", "symbol": "LIPO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1742409898, "marketState": "REGULAR", "shortName": "Lipella Pharmaceuticals Inc.", "longName": "Lipella Pharmaceuticals Inc.", "exchange": "NCM", "messageBoardId": "finmb_35907207", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.8728107, "regularMarketPrice": 2.2999, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1671460200000, "regularMarketChange": 0.019900084, "regularMarketDayRange": "2.16 - 2.32", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2339034, "fiftyTwoWeekLowChange": 0.27990007, "fiftyTwoWeekLowChangePercent": 0.1385644, "fiftyTwoWeekRange": "2.02 - 12.0", "fiftyTwoWeekHighChange": -9.7001, "fiftyTwoWeekHighChangePercent": -0.8083417, "fiftyTwoWeekChangePercent": -64.84375, "epsTrailingTwelveMonths": -4.29, "epsForward": -3.2, "fiftyDayAverageChange": -0.6609199, "fiftyDayAverageChangePercent": -0.22322191, "twoHundredDayAverageChange": -1.17189, "twoHundredDayAverageChangePercent": -0.33754635, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-12-20", "cryptoTradeable": false, "displayName": "Lipella Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]